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Abstract
Epileptic activity is generally induced in experimental models by local application of epileptogenic drugs, including
pentylenetetrazol (PTZ), widely used on both vertebrate and invertebrate neurons. Despite the high prevalence of this
neurological disorder and the extensive research on it, the cellular and molecular mechanisms underlying epileptogenesis
still remain unclear. In this work, we examined PTZ-induced neuronal changes in Helix monosynaptic circuits formed in vitro,
as a simpler experimental model to investigate the effects of epileptiform activity on both basal release and post-tetanic
potentiation (PTP), a form of short-term plasticity. We observed a significant enhancement of basal synaptic strength, with
kinetics resembling those of previously described use-dependent forms of plasticity, determined by changes in estimated
quantal parameters, such as the readily releasable pool and the release probability. Moreover, these neurons exhibited a
strong reduction in PTP expression and in its decay time constant, suggesting an impairment in the dynamic reorganization
of synaptic vesicle pools following prolonged stimulation of synaptic transmission. In order to explain this imbalance, we
determined whether epileptic activity is related to the phosphorylation level of synapsin, which is known to modulate
synaptic plasticity. Using western blot and immunocytochemical staining we found a PTZ-dependent increase in synapsin
phosphorylation at both PKA/CaMKI/IV and MAPK/Erk sites, both of which are important for modulating synaptic plasticity.
Taken together, our findings suggest that prolonged epileptiform activity leads to an increase in the synapsin
phosphorylation status, thereby contributing to an alteration of synaptic strength in both basal condition and tetanus-
induced potentiation.
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Introduction
Epilepsy, a neurological disorder affecting 0.5–1% of the
population, is characterised by abnormal electrical discharges in
the brain and seizures. Despite high prevalence and extensive
research, the mechanisms underlying both the onset and the
progression of epilepsy still remain unclear.
In parallel to vertebrates, invertebrate preparations have been
valuable tools in the study of epileptogenesis. A large body of
literature uses the buccal ganglia of the land snail, genus Helix, as a
good experimental system to study epileptiform activity [1]. Helix
neurons are sensitive to epileptogenic drugs and have been
extensively investigated as regards their electrophysiological [2–4],
morphological [5] and epileptological [6–8] properties. Generally,
epileptiform activity is often induced by local application of
epileptogenic drugs, such as pentylenetretazol (PTZ), commonly
employed in both vertebrate and invertebrate preparations. When
PTZ is applied to Helix neurons, the response discharge pattern
changes rapidly from a pre-convulsive state to paroxysmal
depolarisation shift (PDS) in the convulsive phase [9]. PDS is an
abnormal prolonged depolarisation with repetitive spiking associ-
ated with alterations in spike generation and is followed by a rapid
repolarisation and hyperpolarisation [10–12]. The results obtained
from experiments on intact ganglia performed to date are difficult
to analyse, due to complexity of the neuronal networks. Moreover,
inhomogeneous delivery of the topically applied drug results in an
inconsistent mix of direct and indirect effects. Therefore, it is
beneficial to have a simpler experimental model to investigate the
molecular mechanisms underlying epileptic-like activity. Inverte-
brate cell cultures are particularly advantageous for several reasons
(reviewed in [13]): first, identifiable Helix neurons can be isolated
from their synaptic inputs and monosynaptic connections can be
formed in vitro [14]; secondly, PDSs evoked by PTZ administration
in snail neurons resemble those in mammalian cortical neurons
[3,9].
Several lines of evidence indicate that synapsin deletion or
mutation is associated with epileptic behaviour [15–21]. Synapsins
are a family of vesicle-associated phospho-proteins clearly
implicated in the modulation of neurotransmitter release by
controlling the availability of synaptic vesicles for exocytosis [22].
These proteins reversibly associate with synaptic vesicles, actin,
microtubules, and other synapsin isoforms in a phosphorylation-
dependent manner [23–27]. In presynaptic terminals, synaptic
vesicles are organized in distinct pools that are functionally defined
depending on their availability for release [28–30]. The reserve
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pool (RP) is defined as a depot of synaptic vesicles from which
release is only triggered during intense stimulation [31–34]. The
readily releasable pool (RRP) is a population of neurotransmitter
quanta that are available for immediate release [35–37]. It has
been proposed that synapsin, through its phosphorylation, plays an
important role in both the maintenance of the RP [15,16,28], and
the mobilisation of vesicles from the RP to the RRP under
conditions of increased presynaptic activity [38–42]. Therefore,
abnormal synapsin function may induce alterations in synaptic
neurotransmission and its modulation that could also lead to an
epileptic phenotype.
In this work, we take advantage of in vitro monosynaptic
connections between B2 neurons isolated from the Helix buccal
ganglia to investigate the effect of PTZ-induced epileptiform
activity on basal synaptic transmission and post-tetanic potentia-
tion (PTP), a form of short-term plasticity. Since we previously
demonstrated that PTP expression is directly correlated to the
phosphorylation of synapsin domain A and B [43,44], we also
evaluated the involvement of these phospho-sites in PTZ-induced
plastic phenomena.
Results
PTZ application induces epileptiform activity in Helix
cocultures
The properties of Helix B2 neurons have been extensively
described in both in vivo and in vitro conditions [4,45,46]. When
paired in culture, these neurons reliably form excitatory synaptic
connections, and display several forms of activity-dependent
synaptic enhancement, including PTP [44]. Both synaptically
isolated and chemically interconnected B2 neurons are usually
silent in culture [47]. Soon after the application of PTZ, we
observed in these cells a peculiar neural activity that can be
divided into three phases (Fig. 1A): (1) a rapid depolarisation that
triggers action potential firing; (2) a progressive acceleration of
firing activity; (3) an epileptic-like phase, in which the discharge
pattern rapidly changed to a regular bursting-rhythm composed of
irregular spikes (Fig. 1B) and, occasionally, PDS (Fig. 1C). In these
cells PTZ treatment induces discharge patterns similar to a PDS
described in the mammalian brain [3], in an extremely dose-
dependent fashion. Previous studies on intact buccal ganglia
defined 10–20 mM PTZ as subthreshold concentrations, while
40 mM PTZ (epileptogenic dose) has been extensively used to
generate epileptiform activity in intact buccal ganglia [9,48]. In
order to determine the appropriate dose in culture, we firstly
investigated the effect of PTZ on synaptically isolated B2 neurons,
perfused with varying concentrations. We observed that cells
treated with final concentrations of 20 mM and 40 mM showed a
similar increase in discharge pattern reaching a mean firing rate of
1.0460.22 spikes/s (n = 12) and 1.1260.14 spikes/s (n = 15),
respectively. However, while a dose of 20 mM PTZ elicited a
long-lasting regular-spiking, the majority of 40 mM PTZ-treated
cells (i.e. .80%) changed their firing pattern to paroxysmal
activity within a few minutes of drug application. Thus, we
consider 40 mM PTZ as a useful concentration to induce
epileptiform activity in our experiments. After washout, we
verified that exposure to PTZ did not induce any alteration in
membrane potential, or input resistance, in B2 neurons hyperpo-
larized to about -80 mV, 30 mV negative to their resting potential
(data not shown).
In order to check possible alterations in postsynaptic receptor
functionality, we evaluated the response to neurotransmitter by
testing the overall sensitivity of B2 neurons to local serotonin
application with a glass electrode attached to a pneumatic
picopump (Fig. 2A,B). Fixed volumes of a 20 mM serotonin
solution were delivered close to neurons, each time placing the tip
of the electrode at the same distance from the soma, i.e. 50 mm,
corresponding to a representative B2 cell diameter. We found that
focal neurotransmitter application induced a similar membrane
depolarisation before (12.0961.77 mV, n = 6) and soon after PTZ
washout (12.1662.06 mV). Comparable responses were observed
testing the same cells both 15 and 30 minutes after drug removal,
12.6161.87 mV and 12.9862.05 mV, respectively. No statisti-
cally significant changes were found in the corresponding rise
times (pre-treatment: 0.9360.05 s; 0 min after washout:
0.9360.07 s; 15 min after washout: 0.9160.06 s; 30 min after
washout: 0.9160.07 s; n = 6; Fig. 2C).
PTZ-induced epileptiform activity alters basal synaptic
transmission
Several factors including changes in synaptic transmission and
its modulation may participate in the induction and the
maintenance of seizure activity. To better investigate whether
epileptic-like activity affects excitatory transmission, we recorded
monosynaptic B2–B2 connections in culture. During PTZ
exposure, we generally observed a rapid potentiation of synaptic
strength followed by a progressive decline in amplitude of EPSPs
recorded from the postsynaptic cell. This resulting reduction in
postsynaptic response may be ascribed to synaptic fatigue, that is
an attenuation of synaptic efficacy during excessive use, such as
during an epileptic seizure. Considering these observations, we
evaluated changes in basal synaptic transmission that occurred
immediately, or resulted from a late rebound of epileptiform
activity.
Five consecutive EPSPs, evoked at the frequency of 0.05 Hz,
were recorded from monosynaptic B2–B2 synapses before (pre-
treatment) and after (0 min after washout) the perfusion of a
40 mM PTZ solution for 15 minutes. We also determined the
reversibility of PTZ action by testing the same synapses 15 and
30 minutes after drug washout (Fig. 3A). We observed significant
changes in amplitude of the first evoked EPSP (n = 13,
F(3,48) = 6.42, P = 0.001, one-way ANOVA, Fig. 3B). Values
recorded before and at the end of PTZ application were similar,
1.4860.18 mV and 1.3160.27 mV, respectively. Conversely, a
statistically significant enhancement occurred 15 and 30 minutes
after washout, reaching 218.30646.77% (15 min after washout:
3.2460.70 mV) and 265.50659.31% (30 min after washout:
3.9460.88 mV) of pre-treatment value. In the control group (no
PTZ application), no difference in the mean amplitude of the first
EPSP was detected at each time-point (pre-treatment:
1.4160.15 mV; 0 min after washout: 1.4860.19 mV; 15 min
after washout: 1.7160.25 mV; 30 min after washout:
1.4160.19 mV; n = 6, Fig. 3C).
At 15 and 30 minutes post-treatment, in addition to the
enhancement in amplitude of the first EPSP, we observed an
exponential decrease in amplitude of the following EPSPs (from
second to fifth) during basal stimulation with a time constant of
about 20–30 s (n = 13, Fig. 3D). A two-way ANOVA for repeated
measures confirmed an overall significant effect of treatment
(F(3,48) = 12.72, P,0.0001) and stimulus number (F(4,48) = 6.00,
P = 0.0001) and a significant treatment by stimulus interaction
(F(12,192) = 3.03, P,0.001). Considering the amplitudes of the
evoked EPSPs, we found that the fifth EPSP was significantly
decreased in its amplitude to 63.4367.21% (15 min after washout)
and 55.7066.76% (30 min after washout) with respect to the first
EPSP. In both cases, synaptic strength depotentiated to a plateau
value of 1.4460.98 mV at 151minutes, and 1.8960.59 mV at
30 minutes after washout. These amplitudes were similar to mean
PTZ Effect on Synaptic Transmission
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Figure 1. PTZ application induces epileptiform activity in Helix B2–B2 monosynaptic connections. (A) Representative electrophysio-
logical recording of PTZ-induced epileptiform activity from a B2–B2 connection in culture. EPSPs were recorded from the postsynaptic cell kept
hyperpolarised to 30 mV below its membrane potential to prevent firing. The application of 40 mM PTZ rapidly generated sustained firing activity in
the presynaptic neuron. Afterwards, the discharge pattern changed from single spikes to a burst firing pattern (B) and PDS episodes (C). PDS is an
abnormal prolonged depolarisation step with superimposed action potentials.
doi:10.1371/journal.pone.0056968.g001
Figure 2. PTZ application does not compromise B2 postsynaptic response to locally applied neurotransmitter. (A) Sample
electrophysiological recordings showing the response to locally applied 20 mM serotonin pulses (5-HT for 1 s; 10 psi) before and after the exposure to
PTZ (at 0, 15 and 30 minutes after drug washout). (B) Bar graph of the mean depolarization evoked by neurotransmitter application. No detectable
changes were observed among the examined groups. (C) Bar graph of the corresponding rise times.
doi:10.1371/journal.pone.0056968.g002
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basal EPSP amplitudes recorded before (1.6560.20 mV) and soon
after the treatment (1.4460.26 mV) where no depression was
detected. In the control group, no significant variation in the EPSP
amplitude was observed at the different time-points (mean basal
EPSP amplitude: pre-treatment: 1.4060.16 mV; 0 min after
washout: 1.4360.20 mV; 15 min after washout: 1.5660.19 mV;
30 min after washout: 1.4560.13 mV; n = 6; Fig. 3E). In both
groups, none of the recorded neurons displayed spontaneous
activity in the time window between stimulations, confirming that
Helix neurons are generally silent in culture.
These results may indicate the presence of a novel form of
synaptic potentiation, as a late rebound of epileptiform activity,
which is ‘‘use’’- but not time-dependent, whereby the increased
strength is similar at 15 and 30 minutes following PTZ washout.
This enhancement was depotentiated following two or three action
potentials.
Finally, we measured the EPSP rise times at all time-points of
treated synapses and we found that PTZ consistently speeded up
the kinetics of release (n = 13, F(3,48) = 6.48, P,0.001, one-way
ANOVA, Fig. 3F). Based on recordings of B2-B2 synapses,
significantly shortened EPSP rise times were present at time 0 and
15 minutes post-treatment, 26.3964.11 ms (P,0.01, Bonferroni’s
post hoc test) and 31.5864.06 ms (P,0.05, Bonferroni’s post hoc
test), respectively, compared to pre-treatment values
(43.1462.58 ms). Subsequently, at 30 minutes after washout
(47.0163.91 ms), the value returned to a similar level as in the
pre-treatment group. No such alteration was observed in the
control group, where rise times were not statistically different at
Figure 3. Epileptiform activity induces a use-dependent synaptic potentiation at B2–B2 synapses. (A) Sample electrophysiological
recordings of five consecutive EPSPs evoked at the basal rate of 0.05 Hz. Synapses were tested before and every 15 minutes after PTZ treatment and
washout. An enhancement of synaptic strength was detectable at both 15 and 30 minutes after drug washout. (B) Bar graph of the mean amplitude
of the first EPSP in treated synapses. EPSP amplitudes recorded before and at the end of PTZ exposure were similar. Conversely, a significant
potentiation of 218.30646.77% and 265.50659.31% of pre-treatment value occurred at 15 and 30 minutes post-treatment, respectively. (C)
Unchanged values were measured in the control group at any time-point. (D,E) Time course of EPSP amplitude in treated and untreated
monosynaptic connections stimulated at 0.05 Hz. Values were expressed as percentages of the first EPSP amplitude to better appreciate the trend of
EPSPs recorded at 15 and 30 minutes after PTZ washout. (F) Bar graph of EPSP rise times measured at each experimental time-point, showing that
epileptiform activity temporarily speeded up the kinetics of release. (G) No significant difference was found in control group.
doi:10.1371/journal.pone.0056968.g003
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any time-point (pre-treatment: 39.6464.10 ms; 0 min after
washout: 39.4463.99 ms; 15 min after washout: 39.1264.99 ms;
30 min after washout: 36.9065.67 ms; n = 6; Fig. 3G).
PTZ-induced epileptiform activity alters the readily
releasable pool and the release probability
Since altered synaptic transmission may result from changes in
quantal parameters of release, namely the size of the RRP and the
release probability (Prel), we characterised synaptic dynamics with
a rapid depletion protocol evoking EPSPs at 10 Hz (100 stimuli) in
both PTZ-treated and untreated monosynaptic connections at
different time-points (Fig. 4A,B). Data were analysed by plotting
cumulative EPSPs and fitting a regression line through the linear
portion of the plot which represents a balance between the rate of
vesicle release and the continual replenishment of the RRP.
Generally, we found that EPSPs declined to a low steady-state
amplitude by the twenty-fifth action potential; therefore values in
the range of 25–100 stimuli were included in this analysis in order
to obtain the best linear fitting (all R2 values were .0.99). From
cumulative amplitude profiles, the y intercept value back-
extrapolated from the regression line yields a rough estimation
of the RRP size at the start of the high frequency stimulation,
while the slope provides an indicator of the RRP replenishment
rate [49–50].
We found that the estimated size of the RRP was significantly
affected by PTZ-induced epileptiform activity (n = 13,
F(3,48) = 19.30, P,0.0001, one-way ANOVA; Fig. 4C). The mean
RRP size decreased from 8.6460.52 mV (pre-treatment) to
4.9360.54 mV, measured soon after PTZ washout (P,0.001,
Bonferroni’s post hoc test), but completely recovered 15 minutes
later (7.4160.75 mV). Afterwards, we observed a statistically
significant increase in the RRP size at 30 minutes post-treatment,
(12.4460.96 mV; P,0.01, Bonferroni’s post hoc test). Conversely,
mock-treated synapses in the control group showed similar values
at different time-points (pre-treatment: 7.8860.93 mV; 0 min
after washout: 6.7760.83 mV; 15 min after washout:
6.5260.70 mV; 30 min after washout: 6.2461.14 mV; n= 5,
Fig. 4D).
No statistically significant changes in slope value were found in
untreated synapses (pre-treatment: 0.9760.04; 0 min after wash-
out: 0.9160.04; 15 min after washout: 0.9760.03; 30 min after
washout: 0.9160.05; n = 5; Fig. 4E), as well as PTZ-treated cells
(pre-treatment: 0.8560.06; 0 min after washout: 0.7960.06;
15 min after washout: 0.8260.08; 30 min after washout:
0.9060.12; n = 13; Fig. 4F), suggesting that the exposure to this
epileptogenic drug did not affect the replenishment rate of the
RRP.
The probability of release (Prel) was calculated as the ratio
between the first EPSP in the train and the estimated RRP.
Indeed, Prel exhibited a reversible increase following epileptiform
activity (n = 13, F(3,48) = 11.59, P,0.0001, one-way ANOVA; Fig.
4G) from 0.1760.01 to 0.2960.02 (P,0.001, Bonferroni’s post hoc
test), measured before and after PTZ treatment, respectively.
During recovery, this parameter slowly decayed to 0.2460.02 at
15 minutes after washout (P,0.01, Bonferroni’s post hoc test), and
reached the pre-treatment value only 30 minutes later
(0.1960.02). On the other hand, no statistically significant
difference was found in the control group (pre-treatment:
0.1860.02; 0 min after washout: 0.1760.02; 15 min after
washout: 0.1960.02; 30 min after washout: 0.2360.04; n= 5,
Fig. 4H).
As a second approach, we also investigated changes in Prel by
measuring the paired-pulse ratio (PPR) from each train. PPR is
defined as the ratio between the amplitude of the second EPSP
and that of the first. One-way ANOVA analysis revealed a
significant effect of PTZ exposure (n = 13, F(3,48) = 6.531, P,0.001;
Fig. 4I), with a decrease in PPR value from 0.7160.02 (pre-
treatment) to 0.5860.04 (P,0.01, Bonferroni’s post hoc test) after
PTZ washout (0 min after washout) and 0.6160.02 (P,0.05,
Bonferroni’s post hoc test) at 15 minutes after drug removal. In
agreement with previous results, we detected a complete recovery
of PPR at 30 minutes after PTZ washout (0.7260.02). Since
previous studies have shown that PPR is inversely related to Prel
[51–53], such changes may indicate a transient increase in Prel
following PTZ treatment. Considering the control group, we
observed similar values at all time-points (pre-treatment:
0.6560.03; 0 min after washout: 0.7160.04; 15 min after
washout: 0.6960.04; 30 min after washout: 0.6260.06; n = 5;
Fig. 4J).
Based on this analysis, we conclude that epileptiform activity not
only temporarily increases the probability of release, but also
induces significant changes in the RRP size at different time-
points. Imbalances of these two parameters may explain the
altered synaptic strength observed during basal transmission.
PTZ treatment impairs post-tetanic potentiation
Besides basal synaptic transmission, we also investigated
whether chemically-induced epileptiform activity affected activi-
ty-dependent synaptic enhancement, i.e. PTP whose properties
have been previously described in B2-B2 monosynaptic connec-
tions [44]. To this aim, we induced PTP before and after perfusion
of 40 mM PTZ (n= 15; Fig. 5A,B) or vehicle alone (n = 5; Fig. 5C)
as a control, then we determined the reversibility of PTZ effect in
the same synapses by testing PTP at 15 and 30 minutes after drug
washout. We observed that PTZ treatment strongly compromised
the expression of PTP, which was not restored even after
30 minutes after drug removal. A two-way ANOVA for repeated
measures confirmed a significant effect of treatment
(F(3,56) = 11.58, P,0.0001) and time (F(14,56) = 113.4, P,0.0001)
and a significant treatment by time interaction (F(42,784) = 7.61,
P,0.0001).
We also analysed the time course of PTP decay fitted to a
mono-exponential function to estimate the decay constant (t) in
both treated and untreated synapses. We measured a t value of
76.7868.95 s in the pre-treatment group, 25.5068.15 s soon after
the washout, 41.3563.37 s at 15 minutes after washout and
49.9661.71 s at 30 minutes (Fig. 5D). On the whole, all the
experimental points recorded after PTZ treatment showed a
significant reduction in PTP decay time (F(3,56) = 10.67, P,0.0001,
one-way ANOVA). The t values calculated in control group did
not significantly change during the stimulation protocol (Fig. 5E;
pre-treatment: 80.7067.57 s; 0 min after washout: 79.7765.91 s;
15 min after washout: 86.2169.76 s; 30 min after washout:
86.84610.45 s).
Taken together, these results indicate that epileptiform activity
induced by PTZ application compromises the capacity of B2–B2
excitatory synapses to undergo activity-dependent synaptic plas-
ticity, affecting PTP amplitude and its decay. Therefore, we can
infer that PTZ treatment affects not only the RRP but also the RP,
preventing synaptic potentiation.
PTZ treatment induces the phosphorylation of synapsin
domain A and B
Since we observed that PTZ treatment affected both the RRP
and the RP, possibly altering the reorganisation of these synaptic
vesicle pools, we tested the hypothesis that this action might be
mediated by synapsin phosphorylation. Helix synapsin (helSyn)
contains well-conserved sites for PKA and CaMKI/IV in domain
PTZ Effect on Synaptic Transmission
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A, named site 1, and for MAPK/Erk in domain B, named sites 4
and 5. We have previously published research on the role of both
sites in the expression of PTP and formation of functional
connections [43,44]. Consequently we focused our attention on
these sites to evaluate changes in their phosphorylation status
induced by epileptic-like activity. As a first approach, we
performed a western blot analysis to investigate PTZ effects on
isolated ganglia, compared with those induced by vehicle alone
(negative control) or with high-extracellular KCl application,
commonly used to induce depolarisation (positive control).
Endogenous synapsin, both total and phosphorylated, was
detected with custom-designed rabbit polyclonal antibodies. The
specificity of a-P1helSyn and a-P4,5helSyn was tested by means of
a dephosphorylation assay on blotted proteins (see Methods). No
signal was detectable, not even after a prolonged exposure,
whereas bands were clearly present in not-dephosphorylated blots
or after reprobing with a-helSyn antibody, thus verifying the
reliability of our antibodies (data not shown).
We checked the effect of PTZ on the total level of synapsin (Fig.
6A) by calculating the ratio of volume (intensity*mm2), adjusted
for the background, between helSyn and actin bands. No
significant differences were found between PTZ- or KCl-treated
samples and control, thus indicating that the synapsin total level
remained unchanged after treatments. According to these results,
we decided to express the level of phosphorylation as a ratio
between phosphorylated and total synapsin immunoreactivity
(defined as phospho-ratio). To this aim, immunoblots hybridised
with a-P1helSyn or a-P4,5helSyn antibodies were reprobed with a-
Figure 4. Epileptiform activity induces opposite changes in the RRP and Prel. (A,B) Cumulative curves of EPSP amplitudes evoked at 10 Hz at
different time-points. The linear part was fitted as described in Methods. (C) Following PTZ exposure, the estimated RRP size, expressed in mV,
significantly decreased soon after washout, recovered at 15 minutes and then increased 30 minutes post-treatment. (D) On the contrary, the RRP
remained unchanged in control group. (E,F) Bar graph of mean values of slopes measured from the linear regression lines, indicating similar vesicle
replenishment rates in both treated and untreated synapses. (G) Bar graph of Prel showing an increase in this parameter following epileptiform
activity which returns to pre-treatment values at 30 minutes after drug washout. (H) No alteration was measured in untreated synapses. (I) Histogram
of mean PPR values obtained from treated B2–B2 synapses. PTZ exposure transiently reduced PPR with a complete recovery at 30 minutes after
washout. (J) No detectable changes in PPR were observed in control group.
doi:10.1371/journal.pone.0056968.g004
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helSyn antibody after the inactivation of peroxidase activity by its
substrate, hydrogen peroxide. This method, unlike classical
stripping, avoids the loss of proteins from membranes. As we
have verified in several tests, the chemiluminescent signal of the
first secondary antibody is completely quenched by treatment with
hydrogen peroxide without interfering with following reprobings.
As shown in Fig. 6B,C, KCl treatment induced a significant
increase in synapsin phosphorylation state at both site 1
(264.6630.08%, n = 7, P,0.001 Student’s t-test) and sites 4 and
5 (214.2643.66%, n = 5, P,0.05 Student’s t-test) with respect to
control. Interestingly, PTZ is also able to induce a statistically
significant, almost two-fold, increase in phosphorylation. In
particular, we measured a phospho-ratio of 176.9618.01%
(n = 7, P,0.01 Student’s t-test) for phospho-site 1, and a
Figure 5. Epileptiform activity impairs PTP induction and decay. (A) Sample electrophysiological recordings of the first post-tetanic EPSPs
evoked 30 seconds after the tetanic stimulation (arrowhead) at B2–B2 synapses. Dashed line indicates the amplitude of the pre-treatment EPSP
evoked before tetanisation. PTP was tested before (pre-treatment) and after 40 mM PTZ treatment at different time-points (0, 15 and 30 minutes
after washout). (B,C) The time course of EPSP amplitude changes in PTZ-treated and control synapses. Values are normalized to the average
amplitude of the last five pre-tetanic EPSPs. A strong impairment in PTP amplitude and decay was detected only in the treated group. (D) Bar graph
of the PTP decay time constants measured in treated B2–B2 synapses showing a large reduction in t. (E) Conversely, values in control group were
similar at all time-points.
doi:10.1371/journal.pone.0056968.g005
PTZ Effect on Synaptic Transmission
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phospho-ratio of 204.2640.41% (n = 5, P,0.05 Student’s t-test)
for phospho-sites 4 and 5, with respect to control value.
Previous studies indicate that synapsin is localised within
presynaptic terminals in the regions occupied by synaptic vesicles
[28,54–62]. We performed immunostaining of cultured seroto-
nergic Helix C1 (Fig. 7A,B) and B2 (Fig.7C,D) neurons to
specifically quantify the PTZ-induced synapsin phosphorylation
at presynaptic structures, namely varicosities. We observed a basal
low-level of fluorescence for both synapsin phospho-sites in
untreated cells, while a double staining for serotonin revealed
the presence of this neurotransmitter in the same structures (left
panels). By contrast, in neurons treated with 20 mM KCl, a
several-fold increase in phospho-synapsin immunoreactivity oc-
curred in presynaptic structures, where synapsin is predominantly
localised (central panels). A similar enhancement of fluorescence
level for site 1, as well for sites 4 and 5, was clearly observable in
neurons fixed after the exposure to 40 mM PTZ (right panels).
Interestingly, we observed a strong decrease in serotonin
immunoreactivity in C1 cells stimulated with either high potassium
or PTZ, confirming that both KCl-induced depolarisation and
epileptiform activity led to a massive release of neurotransmitter
and vesicle depletion.
To further test the idea that the level of synapsin phosphory-
lation is enhanced during epileptiform activity, we quantified the
fluorescence intensity from varicose structures of Helix B2 neurons
(Fig. 8A,B) treated with either subthreshold (10 or 20 mM) or
epileptogenic concentration (40 mM) of PTZ. As a positive
control, cells were stimulated with various concentrations of KCl
(2.5, 5, 10 or 20 mM). Variations in phospho-synapsin levels were
taken into account by normalizing the relative amounts of
fluorescence detected in varicosities with those measured in their
proximal neurite. We calculated a varicosity/neurite intensity ratio
that also relies on synapsin localisation at presynaptic structures
(modified from [63]). As regards helSyn PKA/CaMKI/IV and
MAPKs phosphorylation sites, one-way ANOVA revealed a
significant effect of treatment for both phospho-site 1
(F(7,446) = 30.46, P,0.0001; Fig. 8C) and phospho-sites 4 and 5
(F(7,454) = 27.75, P,0.0001; Fig. 8D), respectively.
Considering synapsin phospho-site 1, we found that 10 mM
KCl is a sufficient concentration to significantly increase its
phosphorylation level (varicosity/neurite ratio: 6.3060.38 vs.
2.9560.17 of control group; P,0.001, Bonferroni’s post hoc test).
Interestingly, B2 cells treated with subthreshold concentrations of
PTZ exhibited similar fluorescence intensities to those measured in
untreated neurons (3.5160.19 and 3.0860.16 for 10 mM and
20 mM PTZ, respectively). Conversely, the application of 40 mM
PTZ resulted in a two-fold increase in varicosity/neurite ratio
(6.4860.39; P,0.001, Bonferroni’s post hoc test), thus indicating
synapsin phospho-site 1 as a molecular target during epileptiform
activity.
Immunostaining specific for synapsin phospho-sites 4 and 5
showed an enhanced phosphorylation status directly proportional
with increasing concentrations of KCl (varicosity/neurite ratio:
control: 2.0760.07; 2.5 mM KCl: 3.4160.19, P,0.05; 5 mM
KCl: 3.4860.19, P,0.05; 10 mM KCl: 6.5160.46, P,0.001;
20 mM KCl: 5.8160.33, P,0.001, Bonferroni’s post hoc test).
Although 10 mM PTZ was not sufficient to significantly change
the phosphorylation level of these sites (3.0860.20), we found a
moderate increase in the varicosity/neurite ratio with the
application of 20 mM PTZ (3.8260.17, P,0.01, Bonferroni’s
post hoc test). Similar to previous results, a 3.5-fold enhancement of
this ratio was detected with the epileptogenic concentration of
40 mM (7.2860.73, P,0.001, Bonferroni’s post hoc test), indicating
that synapsin domain B, as well as domain A, is a target of PTZ-
promoted phosphorylation events.
In another set of experiments, we quantitatively determined the
phosphorylation state of synapsin measuring the varicosity/neurite
ratio in cells treated with 40 mM PTZ for 15 minutes and then
fixed soon after washout, or 15 and 30 minutes after drug removal
(Fig. 9A,B). We observed that PTZ treatment promoted a
remarkable enhancement of varicosity/neurite ratio in phospho-
site 1, (F(3,572) = 18.83, P,0.0001, one-way ANOVA; Fig. 9C)
from 2.9960.09 (pre-treatment) to 6.7260.74 (0 min after
Figure 6. PTZ treatment increases synapsin phosphorylation of both domain A and B in Helix ganglia. (A) Western blot analysis of
helSyn expression level normalized to actin along with histograms presenting average densitometric values. Values were similar in all experimental
groups. (B,C) Mean density value of phospho-helSyn compared to that of total helSyn (phospho-ratio). Both phospho-site levels were increased by
KCl or PTZ application.
doi:10.1371/journal.pone.0056968.g006
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washout; P,0.001, Bonferroni’s post hoc test). At 15 and
30 minutes after washout we determined a varicosity/neurite
ratio of 5.0660.24 (P,0.001, Bonferroni’s post hoc test) and
4.5560.17 (P,0.01, Bonferroni’s post hoc test), respectively.
Therefore, the increased phosphorylation level of synapsin in site
1 appeared to show a slow declining tendency after PTZ removal,
remaining significantly higher with respect to control even
30 minutes after epileptiform activity.
Similar results were observed for phospho-sites 4 and 5 where
drug-induced epileptiform activity promoted a statistically signif-
icant increase in varicosity/neurite ratio (F(3,588) = 102.4,
P,0.0001, one-way ANOVA; Fig. 9D) from 2.2860.08 (pre-
treatment) to 7.1060.27 (0 min after washout; P,0.001, Bonfer-
roni’s post hoc test). Lower values, but still significantly higher with
respect to control, were detected at 15 and 30 minutes after
washout, 5.8660.23 (P,0.001, Bonferroni’s post hoc test) and
5.0560.17 (P,0.001, Bonferroni’s post hoc test), respectively.
In conclusion, the data obtained from western blot assay and
immunostaining analysis provide strong evidence that the PTZ-
induced epileptiform activity leads to an increase in synapsin
phosphorylation level at both phospho-sites 1 and 4/5, possibly
through the activation of the corresponding kinase pathways, i. e.
PKA, CaMKI/IV and MAPK/Erk.
Discussion
Epileptiform activity alters basal synaptic transmission
Reliable synaptic transmission is supported by proper organi-
sation of synaptic vesicle pools. Neurotransmission failure may
result from sustained neural activity, such as during an epilepti-
form episode, where continuous exocytosis of neurotransmitter
prevails over mechanisms that replenish neurotransmitter avail-
ability. Indeed, epileptic seizures induce remarkable alterations of
the dynamics of vesicle redistribution into the synaptic apparatus.
Ultrastructural studies on synapses of the rat central nervous
system revealed two opposing changes after seizure termination:
an immediate dramatic depletion of synaptic vesicles [64], similar
to that observed after other intense stimulation conditions [65,66],
and a successive increase in the number of vesicles near the active
zone [67,68]. This relocation of vesicles towards the synaptic cleft
contributes to raising the activity of the epileptic focus area,
increasing the supply of neurotransmitter [69]. Although synaptic
fatigue during epileptic-like activity may be protective against
excessive excitability in the nervous system, the strengthening of
excitatory synapses may worsen the epileptic phenotype.
Our results corroborate this evidence. The observed gradual
decline of EPSP amplitude and the marked reduction in serotonin
immunoreactivity during epileptiform activity confirm the loss of
neurotransmitter from presynaptic structures. By using a rapid
depletion technique [49], we have also estimated that the size of
the RRP is reduced soon after drug washout without changes in
the vesicle replenishment rate. However, no alteration in basal
transmission is detectable at this time-point (0 min after washout),
since similar values in EPSP amplitude and time course were
recorded before and after treatment. This discrepancy could be
explained with the parallel strong increase in Prel, deduced from
the cumulative EPSP plots, that may compensate for the lack of
vesicles during basal stimulation.
Previous studies have shown that the paired-pulse ratio is
inversely related to release probability, and has been frequently
used to examine vesicular release dynamics [51–53]. At Aplysia
synapses, changes in PPR are predominantly determined by Prel
Figure 7. PTZ-induced epileptiform activity promotes massive neurotransmitter release and phosphorylation of synapsin at
presynaptic varicosities. Epifluorescence micrographs sample images of Helix C1 neurites and varicosities immunolabelled with rabbit a-P1helSyn
(A) or a-P4,5helSyn antibodies (B), in green. Cells were fixed after 15 minutes of incubation with culture medium (control, left of each panel), or 20 mM
KCl (middle of each panel) or 40 mM PTZ (right of each panel). Both treatments increased synapsin phospho-levels of site 1 and sites 4/5. A double
staining for serotonin (5-HT), in red, revealed a strong loss of immunoreactivity, indicative of a massive neurotransmitter release in KCl and PTZ-
treated cells. Sample images of Helix B2 neurites and varicosities treated as above described and then immunolabelled with rabbit a-P1helSyn (C) or
a-P4,5helSyn antibodies (D). Scale bars: 10 mm.
doi:10.1371/journal.pone.0056968.g007
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[70,71]. This analysis revealed a transient reduction in PPR at B2–
B2 synapses following PTZ treatment, corresponding to an
increase in Prel, consistent with our interpretation of cumulative
EPSP plots. Hence, these data suggest a dynamic modulation of
Prel after epileptiform activity that may affect release kinetics, since
a concomitant shortening of EPSP rise times has been observed.
Both parameters completely recovered at 30 minutes after drug
removal. In our model, this increase in probability and speed of
neurotransmitter release may reflect a positive modulation of
release machinery induced by epileptiform activity, perhaps
through transient protein modification such as phosphorylation
or increased Ca2+ concentration in the presynaptic terminals [72].
Alternatively, we cannot exclude the rapid activation of other
active zones that were previously silent [73]. An enhancement in
amplitude of evoked postsynaptic currents and a shortening of
their rise times have also been described in basolateral amygdala
neurons of rats which undergo to epileptic discharges induced by
electrical kindling [74]. Shoji and colleagues proposed that these
modifications probably resulted from an increase in Prel at nerve
terminals. Indeed, our evidence supports these findings.
We also observed that basal transmission not only recovers at 15
and 30 minutes post-PTZ treatment, but also shows a significant
increase in EPSP amplitude which rapidly decays to control values
following a few action potentials. This decay exhibits a time course
comparable to that described in homosynaptic depression of other
gastropod synapses [75–77]. Here, these differences in synaptic
efficacy may be ascribed to opposite changes between the size of
the RRP and the Prel. While the higher Prel required 30 minutes
after drug washout to return to pre-treatment level, the estimated
RRP showed a progressive increase in size. Imbalances of these
two parameters have often been associated with facilitating and
depressing synapses [78]. In previous studies on Helix neurons,
some forms of synaptic enhancement have been attributed to
postsynaptic receptor sensitisation [79]. By applying small
amounts of serotonin, we assessed that the overall neurotransmit-
ter responsiveness of treated B2 neurons does not change after
PTZ exposure at different time-points. Nevertheless, we cannot
totally exclude a possible interaction because it is difficult to
discriminate between extrasynaptic receptors and postsynaptic
receptors in the synaptic cleft which may show different functional
properties depending on their localisation [80–82].
Taking into account that we never observed synaptic depression
at B2–B2 synapses in vitro, we define the above described EPSP
amplitude decrease as a depotentiation rather than a synaptic
depression, since values decline to a baseline that is similar to the
pre-treatment mean EPSP amplitude. In view of this, we can
speculate that chemically-induced epileptiform activity effectively
promotes a short-lasting form of synaptic plasticity in our system.
Our observations bear resemblance to a novel form of short-term
potentiation described in reconstructed synapses between Lymnaea
VD4 and LPeD1 neurons, which exhibit an enhancement of basal
transmission with comparable decay kinetics following tetanisation
[83]. In both cases, there is an increase in the first EPSP amplitude
followed by a rapid depotentiation upon triggering a few action
potentials. The same synaptic enhancement is displayed when
stimulated at different time-points, since we observed that the
Figure 8. PTZ-application promotes phosphorylation of synapsin domain A and B in a dose-dependent fashion. (A,B) Representative
acquisitions of B2 varicosities expressed in pseudocolour, from purple (scarcely stained) via green (weakly stained) to red (most strongly stained), to
better appreciate differences in synapsin phosphorylation. Treatments with 20 mM KCL and 40 mM PTZ were shown. Scale bars: 2 mm. (C,D)
Quantification of synapsin phospho-levels from varicosities of B2 neurons processed with the indicated treatments and immunolabelled with either
a-P1helSyn or a-P4,5helSyn antibodies. A ratio between the intensities of varicosity and its proximal neurite has been calculated. The corresponding
number of examined varicosities (n) is indicated on each bar.
doi:10.1371/journal.pone.0056968.g008
PTZ Effect on Synaptic Transmission
PLOS ONE | www.plosone.org 10 February 2013 | Volume 8 | Issue 2 | e56968
potentiated response is similar from 15 to 30 minutes following
epileptiform activity. On the basis of these properties, these forms
of plasticity have been defined as use- rather than time-dependent
[83]. A similar use-dependent dynamic upregulation of synaptic
transmission has also previously been described in the CA1 area of
rat hippocampus [84], thus excluding that these synaptic
modulations are restricted to invertebrate neurons.
The precise mechanisms by which use-dependent plasticity is
elicited still remain unknown. However, new evidence has
emerged to support a direct involvement of the same signal
transduction pathways already implicated in modulation of
neurotransmitter release. For instance, use-dependent potentiation
at Lymnaea VD4–LPeD1 synapse requires the activation of
Ca2+a˜ calmodulin dependent kinase II (CaMKII) in presynaptic
terminals. As a downstream target, synapsin is one of the putative
phosphorylation substrates that has been proposed to play a role in
this form of plasticity [83].
Epileptiform activity alters post-tetanic potentiation
Post-tetanic potentiation is a form of short-term homosynaptic
plasticity triggered by high-frequency stimulation. The resulting
increase in synaptic efficacy is a sum of several concurrent
mechanisms that modulate the efficacy of neurotransmitter release
[85–87] and the different steps of the synaptic vesicle cycle
[85,86,88,89]. While it has been clearly demonstrated that PTP
strongly correlates with an increase in the RRP, due to the
recruitment of synaptic vesicles from the RP during high-
frequency activity [32,90,91], the degree of contribution of Prel
to PTP maintenance is still debated. It has been demonstrated that
the tetanus-induced enhancement of Prel decays rapidly with a fast
time constant not comparable with PTP decay kinetics [92].
Figure 9. PTZ-induced epileptiform activity promotes a prolonged phosphorylation of synapsin domain A and B. (A,B) Pseudocolour
representative acquisitions of B2 varicosities and neurites fixed before 40 mM PTZ treatment and every 15 minutes after drug washout. Cells were
then immunolabelled with either a-P1helSyn or a-P4,5helSyn antibodies, as indicated. Scale bars: 2 mm. (C,D) Bar graphs showing the mean varicosity/
neurite fluorescence ratio for synapsin phospho-levels measured as previously reported. A statistically significant increase in synapsin
phosphorylation at both phospho-sites was observed even 30 minutes after PTZ washout. The corresponding number of examined varicosities
(n) is indicated on each bar.
doi:10.1371/journal.pone.0056968.g009
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In the present work, we show that PTP is significantly affected
in B2–B2 monosynaptic connections following epileptiform
activity, with a large decrease in both amplitude and duration
that lasts even 30 minutes after PTZ removal. Since 15 minutes is
a sufficient period of time to allow the complete re-establishment
of synaptic functionality (see control group), we can therefore
speculate a PTZ-induced alteration of the molecular effectors
responsible for PTP expression and maintenance. One possible
explanation of the PTP deficit is a partial occlusion resulting from
prolonged firing activity, however this hypothesis is in contrast
with our results. Following PTZ application, at B2–B2 synapses we
observed an unaltered vesicle replenishment rate, similar postsyn-
aptic responses to neurotransmitter application, an enhancement
of Prel and faster kinetics of vesicle release, deduced from the
shorter rise time of EPSPs. Taking into account these elements,
PTP would be expected to increase in its amplitude and/or decay
rather than being impaired.
To conclude, our experiments on basal transmission and PTP
expression may suggest an impairment in dynamic reorganisation
of synaptic vesicle pools following the massive release of
neurotransmitter due to the sustained firing induced by PTZ.
The supply of synaptic vesicles from the RP to the RRP is one of
the key steps that sustain the enhanced neurotransmitter release
during PTP [33,85,91–93]. As previously mentioned, synapsin is a
good candidate for such dysregulation in the presynaptic terminal,
since it is clearly implicated in maintaining presynaptic vesicular
pools and in regulating vesicle mobility during short-term plasticity
[94–98].
There are several lines of evidence suggesting a key role of
synapsin in PTP both in mammalian and invertebrate synapses.
Mice lacking synapsin II or double synapsin I/II knockouts exhibit
a strong reduction in PTP and learning deficits [16,99].
Intraneuronal injection of specific anti-synapsin antibodies reduces
PTP at Aplysia cholinergic synapses [94]. In Helix neurons we
previously demonstrated that PTP is strongly related to PKA,
CAMKI/IV and MAPK/Erk kinase pathway activation and thus
to the phosphorylation of helSyn at the corresponding consensus
sites [43,44]. In agreement with our hypothesis, the PTZ-induced
reduction in PTP amplitude observed in this study is similar to
those described in B2–B2 synapses overexpressing a pseudopho-
sphorylated mutant form of helSyn presynaptically [44]. These
data suggest that cycles of phosphorylation/dephosphorylation are
required for proper activity of synapsin during synaptic plasticity.
The fact that we observed a prolonged phosphorylation state in
both synapsin phospho-sites (high levels still present 30 minutes
after PTZ washout) may explain the persistence of PTP
impairment at this time-point. Recently, the importance of these
phosphorylation sites for PTP expression has also been confirmed
in mouse glutamatergic autapses [100].
Epileptiform activity induces synapsin phosphorylation
Synapsins have been frequently implicated in epilepsy. The
single, as well as the double and triple, synapsin knockout mice
suffer from epileptic seizures [15,16,18,19,21], consistent with an
imbalance in excitability of the nervous system. Genetic screens
identify several mutations in synapsin genes associated with human
epilepsy and autism disorders [17,20]. Moreover, biochemical
studies have indicated that administration of convulsant drugs, i.e.
PTZ or picrotoxin, results in an increased phosphorylation level of
a wide range of intracellular proteins [101], including synapsin I
[102]. Although an extensive identification of these substrates still
remains to be achieved, the phosphorylation events associated with
PTZ application seem to be calcium-dependent since they are
reduced in calcium-free medium or in presence of chelating agents
[103–106]. Hence, a wide range of kinase pathways and molecular
effectors are most likely activated during PTZ-induced epilepti-
form activity and therefore may contribute to the overall effects in
synaptic functions that we described in our experimental model.
In this work, we have selectively analysed the phosphorylation
levels of Helix synapsin domain A (site 1) and B (sites 4 and 5)
regulated by PKA/CaMKI/IV and MAPK/Erk, respectively.
Our findings show that synapsin phosphorylation is strongly
enhanced in both sites by application of PTZ at the epileptogenic
dose of 40 mM, but not at 20 mM, defined as a subthreshold
concentration [9,48]. Interestingly, intracellular recordings reveal
that application of either 20 or 40 mM PTZ triggers a similar
mean firing rate (about 1 Hz), but only the concentration of
40 mM determines the switch to burst activity and PDS.
Therefore, we may speculate that synapsin phosphorylation is
directly promoted by epileptiform activity rather than by the
prolonged low frequency firing. A large body of literature suggests
that phosphorylation of synapsin site 1 results in decreased actin
[107] and synaptic vesicle binding [23], while sites 4 and 5 seem to
be predominantly involved in triggering actin polymerisation and
bundling [108]. Through this mechanism, both phospho-sites play
an important role in modulating neurotransmitter release in
vertebrates [39,109–112] and invertebrates [43,44,113]. Accord-
ing to our results, a prolonged phosphorylation of synapsin may be
responsible for both the increase in the RRP size, thus altering
basal synaptic transmission, and the alteration of vesicle pool
organisation (e.g. clustering vesicles into the RP), leading to PTP
impairment. It is likely that, after vesicle depletion, recycled
vesicles might be clustered less efficiently into the RP, thus
increasing the number of releasable vesicles (see Fig. 10).
The pathologic activation of the same molecular pathways that
regulate synaptic strength in short- and long-term plasticity may
lead to an imbalance between excitatory and inhibitory transmis-
sion degenerating into an epileptic episode. Accordingly, evidence
from several animal models suggests a possible role for both PKA
[114–119] and MAPK/Erk [120–124] in the development and
maintenance of increased neural excitability and epileptiform
activity.
Conclusions
In this work, we provide compelling evidence that prolonged
epileptiform activity leads to an increase in the synapsin
phosphorylation state, possibly losing synaptic vesicle pool
segregation, thus contributing to an alteration of synaptic strength
in both the basal condition and tetanus-induced potentiation.
Through this mechanism, the long-lasting firing activity and the
repetitive phosphorylation events may induce a protracted
modification of synaptic transmission which could dramatically
increase the severity of epileptic seizures.
Methods
Materials
All reagents and materials were of analytical grade and
purchased from Sigma (Milan, Italy), unless stated otherwise.
Cell culture
Juvenile Helix aspersa land snails were purchased from local
breeders. Cell cultures were performed as previously described
[14,44], under either adhesive or non-adhesive conditions.
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PTZ treatment
In order to induce epileptiform activity in Helix neurons, PTZ
was dissolved in L-15 Leibovitz culture medium to a final
concentration of 40 mM (epileptogenic dose; see [9,48]). Where
expressively specified, subthreshold concentrations of 10 and
20 mM were employed. In some experiments, isolated or
chemically interconnected B2 neurons were perfused with PTZ
solution during electrophysiological recording. After 15 minutes,
PTZ was rapidly washed out (7.5 ml/min) with 5 volumes of the
recording chamber (about 10 ml). Flow was actively controlled by
a peristaltic pump (Ismatec ISM829; Glattbrugg, Switzerland).
Cells that exhibited neither bursting activity nor PDS were not
included. As a control, the same stimulation protocols were
applied with the perfusion of culture medium for 15 minutes
without the presence of PTZ (control).
Electrophysiological recording
Conventional intracellular recordings of synaptic activity were
performed in current-clamp mode as previously reported [43,44].
Signals were recorded with an Axoclamp 900A amplifier
(Molecular Devices, Sunnyvale, CA, USA) and digitally recorded
via a Digidata 1322A interface (Molecular Devices). Offline
analysis was performed with Axoscope and Clampfit software
products (Molecular Devices).
The response to focal application of serotonin was evaluated
before and after PTZ treatment on B2 neurons kept hyperpolar-
ised 30 mV below their resting potential (about -80 mV) to
prevent firing. A solution of 20 mM serotonin in L-15 medium was
loaded into a patch-clamp glass electrode and focally applied using
short pressure pulses (5 pulses of 1 second at 10 psi) delivered
through a pneumatic picopump (PV820, WPI, Sarasota, FL),
connected to the electrode holder. In each experiment, the tip of
the electrode was positioned 50 m distance from the somata,
corresponding to a representative B2 cell diameter. Measured
postsynaptic responses were averaged to provide the amount of
depolarisation induced by each pulse. In order to avoid the
phenomenon of desensitisation, neurons were adequately perfused
with fresh medium between each application.
To analyse epileptiform-induced changes in basal synaptic
transmission and short-term plasticity, B2–B2 pairs were tested
48 hours after cell-cell pairing for the presence of a chemical
monosynaptic connection. Soma-soma pairs that showed electrical
coupling were not used. Generally, presynaptic neurons were
stimulated five times to fire action potentials and corresponding
EPSPs were recorded in postsynaptic cells kept hyperpolarised to -
80 mV. Suprathreshold stimulation was triggered by a Pulse-
master A300 stimulator (WPI, Sarasota, FL, USA) at the basal
frequency of 0.05 Hz before (pre-treatment) and after perfusion of
a 40 mM PTZ solution for 15 minutes, starting 0 min after
washout. Afterwards, synapses were tested again at 15 and
30 minutes after drug washout. During the entire protocol,
neurons were continuously monitored to check any spontaneous
activity between stimulations. To evaluate the time course of EPSP
amplitude, values were expressed as percentage of the first evoked
EPSP. EPSP rise times were measured between 10% and 90% of
its peak amplitude.
The induction and quantification of PTP at B2–B2 synapses
were performed as previously reported [44]. For statistical analysis,
post-tetanic EPSP amplitudes were normalised to the mean
amplitude of the last five pre-tetanic EPSPs. The PTP decay time
constant t was obtained by exponential curve-fitting procedures
using the statistical software GraphPad Prism ver.5 (GraphPad
Software, San Diego, CA, USA).
Estimation of the RRP size, Prel and PPR
The size of the RRP and Prel were calculated at different time-
points in both PTZ-treated and untreated monosynaptic connec-
tions by performing a cumulative amplitude analysis [49].
Following this method, we measured the cumulative sum of EPSP
amplitudes during 100 repetitive stimuli applied at 10 Hz
(depleting stimulus). During stimulation, EPSPs declined and
reached a steady-state, typically interpreted as the ongoing
Figure 10. Epileptiform activity increases the synapsin phosphorylation status, thus leading to an altered basal synaptic
transmission. Hypothetical cascade of intracellular events occurring at presynaptic terminal during epileptiform activity. At resting potential (A),
unphosphorylated synapsin tethers small vesicles into the RP. Prolonged paroxysmal activity (B) that induces the activation of several kinase
pathways and promotes vesicle mobilization through synapsin phosphorylation, leads to a very large release of neurotransmitter (C). Afterwards,
although recycled vesicles start to reorganize themselves into synaptic pools (D), the enhanced phosphorylation status of synapsin compromises
pool maintenance, thus increasing the number of free vesicles that are ready to be released (E).
doi:10.1371/journal.pone.0056968.g010
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replenishment of the depleted RRP [49,125,126]. The number of
data points to include in the linear fitting of the steady-state phase
was evaluated by calculating the best coefficient of determination
(R2) comprising the maximal number of values starting from the
last stimulus. At B2–B2 synapses, the cumulative amplitude profile
showed the best linear course after the first 25 stimuli, in both
treated and untreated synapses. Thus, all data points in the range
between 25 and 100 were fitted by linear regression obtaining R2
values .0.99 at each examined synapse. The y-intercept of fitted
line, back-extrapolated at time 0, was used as an estimate of the
number of quanta in the RRP, expressed in mV. The slope of the
regression line provided an indicator of the rate of vesicle
replenishment.Subsequently, the probability of release (Prel) was
calculated as the ratio between the first EPSP evoked in the train
and the estimated RRP size.
For each train of EPSPs, the paired-pulse ratio (PPR) was
calculated as the ratio between the amplitude of the second EPSP
and that of the first one (i.e. EPSP2/EPSP1 amplitude) with an
interpulse interval of 100 ms.
Phospho-specific helSyn antibodies and
dephosphorylation assay
For Helix Synapsin (helSyn), the phospho-peptides
CLRRRF(S9)*SGDLQGEANEKED (PKA and CaMKI/IV
phosphorylation site on Ser 9, indicated as site 1),
CNFKKGP(S36*)PS and APN(S42*)PSKSAC (MAPK/Erk phos-
phorylation sites on Ser 36 and 42, respectively named sites 4 and
5) were manufactured by Inbios International Inc. (WA, USA).
OVA or SMCC-conjugated peptides were used to immunise
rabbits and the resultant sera were affinity-purified (antibody anti-
helSyn phosphorylated on site 1, a-P1helSyn) or supplied
unpurified (antibody anti-helSyn phosphorylated on site 4 and 5,
a-P4,5helSyn) (Inbios International Inc.). The specificity of helSyn
phospho-specific antibodies was tested on western blot by means of
a dephosphorylation assay. Specifically, a western blot was
performed, in which the same sample was loaded several times.
The membrane was divided into four parts. Two parts, intended
as controls, were probed with either a-helSynP4,5 or a-helSynP1
according to the protocol described in the following section. The
other two parts underwent a treatment with Calf-intestinal alkaline
phosphatase (CIAP, 1 U/ml, in presence of its buffer) (Promega,
WI, USA), that catalyzes the removal of phosphate groups from
the blotted proteins, overnight at 37uC with gentle shaking. The
day after, these membranes were rinsed twice in TTBS and
probed with the phospho-specific antibodies. No bands appeared
on the films thus confirming the specificity of helSyn phospho-
specific antibodies. To exclude protein loss, the same membranes
were re-probed with a-helSyn antibody (Inbios International Inc.),
which recognizes Helix synapsin, either phosphorylated or not.
Western blot
For 7 independent experiments, cerebral ganglia and the
subesophageal ring were dissected from adult specimens of Helix
aspersa. Ganglia were transferred in L-15 medium alone (control)
or with addition of 40 mM PTZ for 1 hour or 60 mM KCl for
5 minutes. Next, ganglia were quickly frozen in liquid nitrogen
and stored at -80uC until lysis. Homogenates were prepared in a
Mixer Mill MM 400 apparatus (Retsch, Verder Group, Nether-
lands) in 20 mM TrisHCl, pH 7.5, containing 1% SDS and
protease inhibitors (1 mM Sodium orthovanadate, 2 mM Sodium
fluoride, 2 mM Sodium pyrophosphate, 1 mg/ml Aprotinin, 1 mM
Pepstatin A, 5 mM EDTA, 1 mM DTT, 1 mM PMSF). Aliquots
of 35 mg total proteins were separated on a 5% to 8% SDS-
polyacrylamide gel and transferred onto a nitrocellulose mem-
brane (Amersham Hybond, GE Healthcare, UK) before being
blocked for 1 hour at room temperature (RT) and then probed
overnight at 4uC with primary antibody diluted to appropriate
concentrations (a-helSyn 1:700; a-P1helSyn 1:150; a-P4,5helSyn
1:100; polyclonal rabbit a-actin 1:200, Sigma). Blots were then
incubated with a horseradish peroxidase-conjugated goat a-rabbit
IgG antibody (1:800, Thermo Fisher Scientific, MA, USA) for 1
hour at RT and visualised using SuperSignal WestPico Chemi-
luminescent reagent (Thermo Fisher Scientific). Hybridisation
with phospho-specific antibodies were subjected to reprobing with
a-helSyn after the inactivation of peroxidase activity by hydrogen
peroxide [127,128]. Western blot films were scanned and the
adjusted volume (after background subtraction) of bands was
quantified using Quantity One software (Bio-Rad Laboratories,
CA, USA). Blots probed with a-helSyn were normalised with
actin. We defined the phospho-ratio parameter as the ratio
between the phospho-specific antibodies and a-helSyn antibody
immunoreactivity. The effects of KCl and PTZ were calculated as
the fold change in phospho-ratio between control and treated
samples.
Immunocytochemistry and fluorescence analysis
To analyse the phosphorylation level of helSyn in varicose
structures, B2 neurons and serotonergic C1 neurons were isolated
and cultured for 3 days under adhesive conditions to promote
neurite growth. After treatment for 15 minutes with appropriate
concentrations of PTZ or KCl, cells were rapidly fixed with 4%
paraformaldehyde in 0.1 M phosphate-buffered saline (PBS;
45 minutes at RT). Where indicated, treated cells were washed
with L-15 culture medium and fixed after a resting period of 15 or
30 minutes. Cultures were then rinsed with PBS (3 times;
10 minutes), blocked with 5% bovine serum albumin and PBS
plus 0.25% saponin (PBS+) (1 hour at RT). Permeabilised cells
were subsequently incubated overnight at 4uC with suitable
primary antibodies appropriately diluted in blocking buffer. After
washing with PBS+, cultures were incubated in blocking buffer
with fluorescent labelled secondary antibodies. After 1 hour at RT,
neurons were rinsed with PBS+ and examined using an Eclipse
TE200 inverted microscope (Nikon Instruments, Tokyo, Japan)
equipped with phase contrast and epifluorescence optics. Images
were captured with a Monochrome Evolution QE camera
(MediaCybernetics, Bethesda, MD, USA). The following antibod-
ies were used: rabbit anti-P1-helSyn (1:250) and anti-P4,5-helSyn
(1:250) custom-designed polyclonal antibodies (Inbios Internation-
al Inc.); mouse anti-serotonin monoclonal antibody (1:70; Dako
A/S, Denmark); rhodamine-conjugated goat anti-mouse (1:200;
Sigma); fluorescein-conjugated goat anti-rabbit (1:200; Sigma).
Quantitative analysis of phospho-synapsin fluorescence were
performed using the Line Profile tool of Image Pro Plus version 6.3
(MediaCybernetics). A varicosity/neurite ratio was calculated from
background-subtracted intensity values measured from varicosities
and their proximal neurites. This parameter takes into account the
synapsin localisation at presynaptic terminals [63]. Small varicos-
ities with a size less than 1.5 mm (corresponding to about 2 mm2 of
area) were not included in analysis. The amount of phosphory-
lation was referred to the ratio obtained from untreated cells.
All figures were assembled using Photoshop CS2 version 9.0
software (Adobe Systems, San Jose, CA).
Statistical analysis
Data were expressed as means 6 s.e.m. Statistical analysis was
performed using GraphPad Prism version 5 (GraphPad Software).
The statistical significance between group means was assessed
using Student’s t-test or ANOVA analysis (one or two-way and
PTZ Effect on Synaptic Transmission
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with or without repeated measures where appropriate) followed by
Bonferroni’s post-hoc test. Significance levels were set at P,0.05. In
the figures, asterisks indicate following significance levels vs.
respective control group: ***, P,0.001; **, P,0.01; *, P,0.05.
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